our solutions
The Future of Orthopedics
IntelliSense Drill Technology®
$2.7B Market
The ONLY drill designed with patient safety in mind. Unprecedented safety features like edge-detection and auto-stop help to keep patients safe and prevent complications.
Lever Action Plate System®
$4.3B Market
Infinitely adjustable to improve alignment and patient outcomes.
Custom Accessories
$650M Market
Our vertical integration allows us to spin up custom solutions – fast.
“
Testimonial
Redefining the Technique of Depth Sensing
“The IntelliSense® Drill represents a quantum leap in drill and depth measurement. The IntelliSense® Drill redefines the technique of depth sensing with unparalleled accuracy that will lessen radiation, minimize screw wastage, and improve patient safety.”
Scott Kozin, MD | Shriners Hospitals for Children – Philadelphia
featured on
Invest In Medical Progress
GUESSWORK HAS NO PLACE
IN THE OPERATING ROOM
The standard of care being used in the operating room hasn’t been updated in decades. Surgeons rely on unsophisticated power tools and plates and a sense of “feel” when performing orthopedic surgeries.
This can result in errors that can be dangerous, lead to long-term patient suffering, and are costly for hospitals and surgeons alike. McGinley Orthopedics is on a mission to change that.
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. REGULATION A OFFERINGS ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
McGinley Orthopaedic Innovations is offering securities through the use of an Offering Statement that the Securities and Exchange Commission (‘SEC”) has qualified under Tier II of Regulation A. While the SEC staff reviews certain forms and filings for compliance with disclosure obligations, the SEC does not evaluate the merits of any offering, nor does it determine if any securities offered are “good” investments.
Rialto Markets LLC (“Rialto”) is registered with the Securities and Exchange Commission (“SEC”) as a broker-dealer, member of Financial Industry Regulatory Authority, Inc. (“FINRA”) and Securities Investor Protection Corporation (“SIPC”) and is the broker-dealer of record on this issuer direct offering.
This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its markets or industry. These statements reflect management’s current views regarding future events based on available information and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are
meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, although management believes that the expectations reflected in the forward-looking statements are reasonable, neither McGinley Orthopaedic Innovations nor anyone acting on its behalf can give any assurance that such expectations will prove to have been correct nor do they have a duty to update any such statements to conform them to actual results.
By accessing this site and any pages on this site, you agree to be bound by our Terms of Use and Privacy Policy, as may be amended from time to time without notice or liability.